Page last updated: 2024-10-24

chlorambucil and Angioedema

chlorambucil has been researched along with Angioedema in 1 studies

Chlorambucil: A nitrogen mustard alkylating agent used as antineoplastic for chronic lymphocytic leukemia, Hodgkin's disease, and others. Although it is less toxic than most other nitrogen mustards, it has been listed as a known carcinogen in the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (Merck Index, 11th ed)
chlorambucil : A monocarboxylic acid that is butanoic acid substituted at position 4 by a 4-[bis(2-chloroethyl)amino]phenyl group. A chemotherapy drug that can be used in combination with the antibody obinutuzumab for the treatment of chronic lymphocytic leukemia.

Angioedema: Swelling involving the deep DERMIS, subcutaneous, or submucosal tissues, representing localized EDEMA. Angioedema often occurs in the face, lips, tongue, and larynx.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jones, L1
Bubel, MA1
Newland, AC1

Other Studies

1 other study available for chlorambucil and Angioedema

ArticleYear
C1 esterase inhibitor as a possible tumour marker in malignant lymphoma.
    Clinical and laboratory haematology, 1985, Volume: 7, Issue:3

    Topics: Angioedema; Chlorambucil; Chlorpheniramine; Complement C1 Inactivator Proteins; Humans; Lymphoma; Ma

1985